Plasma levels of alpha crystalline antibodies in NSCLC patients – Diagnostic significance Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
C-reactive protein in community acquired pneumonia – Correlation with main clinical indices Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Is serum cholesterol a risk factor for asthma? Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
EGFR and hTERT expression in high risk COPD patients – clinical application Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
The serum levels of endothelin (ET-1); an activation marker and prognostic indicator in sarcoidosis? Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
LSC 2010 Abstract: Possible effect of GSTM1 and GSTT1 polymorphisms on the risk for development of COPD and total antioxidant plasma capacity Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010
Elevated serum levels of oxidized low-density lipoprotein in COPD patients Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013
Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
A comparative study of the correlations of the COPD assessment test (CAT) scores and high sensitive CRP levels to SPO2 , FEV1 , BODE index, and exacerbation rate Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010
Decreasing level of serum ADA: A valuable predictor of treatment in smear positive tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Serum total cholesterol, HDL-C and LDL-C levels significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 860s Year: 2006
Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008
Increased levels of angiopoietin 1 & 2 in sputum supernatant in smoking asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Principles of optimization of anti-inflammatory therapy in COPD patients (pts) due to C-reactive protein (CRP) level Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Serum procalcitonin level: clinical significance Source: Eur Respir J 2011; 37: 723 Year: 2011